Lomitapide in homozygous familial hypercholesterolemia-Reference-Cited by-同舟云学术

Lomitapide in homozygous familial hypercholesterolemia

Published:2018-03 Issue:3 Volume:19 Page:83-90
ISSN:1558-2027
Container-title:Journal of Cardiovascular Medicine
language:en
Short-container-title:Journal of Cardiovascular Medicine

Author:

Sperlongano Simona,Gragnano Felice,Natale Francesco,D’Erasmo Laura,Concilio Claudia,Cesaro Arturo,Golia Enrica,Crisci Mario,Sperlongano Rossella,Fimiani Fabio,Russo Mariagiovanna,Arca Marcello,Limongelli Giuseppe,Calabrò Paolo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference32 articles.

1. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

2. Canadian Cardiovascular Society position statement – Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease

3. Homozygous familial hypercholesterolaemia

4. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment

5. Genetic heterogeneity of autosomal dominant hypercholesterolemia

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA);Nutrition, Metabolism and Cardiovascular Diseases;2024-08

2. Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events;Pharmacology & Therapeutics;2023-10

3. Alpha-lactalbumin isolated from camel milk on hyperlipidemia and hyperglycemia in experimental mice;NATIVA;2023

4. Efficacy and Safety of Lomitapide in Homozygous Familial Hypercholesterolaemia: A Systematic Review;Reviews in Cardiovascular Medicine;2022-04-26

5. New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia;Heart Failure Clinics;2022-01